Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
Authors
Keywords
-
Journal
Microorganisms
Volume 9, Issue 7, Pages 1382
Publisher
MDPI AG
Online
2021-06-25
DOI
10.3390/microorganisms9071382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contribution of noncanonical antigens to virulence and adaptive immunity in human infection with enterotoxigenic E. coli
- (2021) F. M. Kuhlmann et al. INFECTION AND IMMUNITY
- Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
- (2021) Kristen A. Clarkson et al. EBioMedicine
- Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model
- (2020) Matteo Stoppato et al. VACCINE
- A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice
- (2020) Pedro Henrique Q. S. Medeiros et al. npj Vaccines
- Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
- (2020) Kristen A. Clarkson et al. mSphere
- Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC
- (2020) Shushan Harutyunyan et al. Vaccines
- Biochemical and immunological evaluation of recombinant CS6-derived subunit enterotoxigenic Escherichia coli vaccine candidates
- (2019) Steven T. Poole et al. INFECTION AND IMMUNITY
- Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
- (2019) John D Anderson et al. Lancet Global Health
- Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
- (2019) Clayton Harro et al. VACCINE
- Serum IgG antibodies to Shigella lipopolysaccharide antigens – a correlate of protection against shigellosis
- (2019) Dani Cohen et al. Human Vaccines & Immunotherapeutics
- A tale of two bacterial enteropathogens and one multivalent vaccine
- (2019) Eileen M. Barry et al. CELLULAR MICROBIOLOGY
- Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro
- (2019) Hyesuk Seo et al. PLoS One
- Adjuvant effect of enterotoxigenic Escherichia coli (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-related enhancement of antibody responses to seven ETEC adhesins (CFA/I, CS1-CS6)
- (2019) Hyesuk Seo et al. Human Vaccines & Immunotherapeutics
- Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
- (2019) Louis-Antoine Barel et al. Human Vaccines & Immunotherapeutics
- Technical product attributes in development of an oral enteric vaccine for infants
- (2019) Jessica A. White et al. VACCINE
- Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference
- (2019) Eileen Barry et al. VACCINE
- Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
- (2019) Subhra Chakraborty et al. npj Vaccines
- Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge
- (2019) James E Meiring et al. CLINICAL INFECTIOUS DISEASES
- Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
- (2019) Firdausi Qadri et al. LANCET INFECTIOUS DISEASES
- Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal
- (2019) Mila Shakya et al. NEW ENGLAND JOURNAL OF MEDICINE
- SslE (YghJ), a cell associated and secreted lipoprotein of neonatal septicemic E. coli induces TLR2 dependent macrophage activation and proinflammation through NFκB and MAP kinase signaling
- (2018) Rima Tapader et al. INFECTION AND IMMUNITY
- Critical Role of Zinc in a New Murine Model of Enterotoxigenic Escherichia coli Diarrhea
- (2018) D. T. Bolick et al. INFECTION AND IMMUNITY
- Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
- (2018) Pardeep Kumar et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development
- (2018) Subhra Chakraborty et al. JOURNAL OF INFECTIOUS DISEASES
- A novel mouse model of Campylobacter jejuni enteropathy and diarrhea
- (2018) Natasa Giallourou et al. PLoS Pathogens
- Purification and Characterization of Native and Vaccine Candidate Mutant Enterotoxigenic Escherichia coli Heat-Stable Toxins
- (2018) Morten Govasli et al. Toxins
- Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex
- (2018) K. Ross Turbyfill et al. mSphere
- Molecular determinants of enterotoxigenic Escherichia coli heat-stable toxin secretion and delivery
- (2018) Yuehui Zhu et al. INFECTION AND IMMUNITY
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
- (2018) Ibrahim A Khalil et al. LANCET INFECTIOUS DISEASES
- Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella
- (2018) Renee M. Laird et al. VACCINE
- Oral cholera vaccines and their impact on the global burden of disease
- (2018) Thomas F. Wierzba Human Vaccines & Immunotherapeutics
- Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin
- (2018) Ephrem Debebe Zegeye et al. Human Vaccines & Immunotherapeutics
- Update on campylobacter vaccine development
- (2018) Frédéric Poly et al. Human Vaccines & Immunotherapeutics
- A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge
- (2018) Esther Ndungo et al. mSphere
- The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
- (2018) John D. Clements et al. mSphere
- Establishment, validation and application of a New World Primate model of ETEC disease for vaccine development
- (2018) Julianne E. Rollenhagen et al. INFECTION AND IMMUNITY
- Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
- (2018) Marjahan Akhtar et al. VACCINE
- Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
- (2018) Min Jung Kim et al. Frontiers in Microbiology
- Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study
- (2018) James A Platts-Mills et al. Lancet Global Health
- Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine
- (2017) Jessica A. White et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
- (2017) Celina Jin et al. LANCET
- The Burden of Enteropathy and “Subclinical” Infections
- (2017) Elizabeth T. Rogawski et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Correlates of protection for enteric vaccines
- (2017) Jan Holmgren et al. VACCINE
- Combination vaccine strategies to prevent enteric infections
- (2017) Richard Walker et al. VACCINE
- Chronic consequences on human health induced by microbial pathogens: Growth faltering among children in developing countries
- (2017) James P. Nataro et al. VACCINE
- Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTa N12S -dmLT protect against STa+ enterotoxigenic Escherichia coli (ETEC) diarrhea in a pig model
- (2017) Rahul M. Nandre et al. VACCINE
- A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
- (2017) Christina W. Obiero et al. Frontiers in Immunology
- Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects
- (2016) Subhra Chakraborty et al. Clinical and Vaccine Immunology
- Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin
- (2016) Qingwei Luo et al. Clinical and Vaccine Immunology
- Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection WithVibrio choleraeO1 El Tor
- (2016) Wilbur H. Chen et al. CLINICAL INFECTIOUS DISEASES
- Development of a live attenuated bivalent oral vaccine against Shigella sonnei shigellosis and typhoid fever
- (2016) Yun Wu et al. JOURNAL OF INFECTIOUS DISEASES
- Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
- (2016) Jie Liu et al. LANCET
- Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine
- (2016) Anna Lundgren et al. VACCINE
- Development of recombinant vaccine candidate molecule against Shigella infection
- (2016) S.T.S. Chitradevi et al. VACCINE
- Presentation matters: Buffers, packaging, and delivery devices for new, oral enteric vaccines for infants
- (2016) Manjari Lal et al. Human Vaccines & Immunotherapeutics
- Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century
- (2016) Mark Anderson et al. Frontiers in Cellular and Infection Microbiology
- Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine
- (2016) Harald Nothaft et al. Scientific Reports
- Shigella Outer Membrane Protein PSSP-1 Is Broadly Protective against Shigella Infection
- (2015) Jae-Ouk Kim et al. Clinical and Vaccine Immunology
- A study of different buffers to maximize viability of an oral Shigella vaccine
- (2015) Lakshmi Chandrasekaran et al. VACCINE
- Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infants
- (2015) Richard I. Walker et al. VACCINE
- An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children
- (2015) Richard I. Walker VACCINE
- The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model
- (2015) Elizabeth B. Norton et al. VACCINE
- Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
- (2015) Christiane Gerke et al. PLoS One
- Development of an Aotus nancymaae Model for Shigella Vaccine Immunogenicity and Efficacy Studies
- (2014) Michael Gregory et al. INFECTION AND IMMUNITY
- Simultaneous Exposure to Escherichia coli Heat-Labile and Heat-Stable Enterotoxins Increases Fluid Secretion and Alters Cyclic Nucleotide and Cytokine Production by Intestinal Epithelial Cells
- (2014) Lisa T. Read et al. INFECTION AND IMMUNITY
- Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
- (2014) Stefan L. Karlsson et al. PLoS One
- Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
- (2014) Anna Lundgren et al. VACCINE
- A capsule conjugate vaccine approach to prevent diarrheal disease caused byCampylobacter jejuni
- (2014) Alexander C Maue et al. Human Vaccines & Immunotherapeutics
- SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains
- (2014) Barbara Nesta et al. PLoS Pathogens
- Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli
- (2013) Samer S. El-Kamary et al. Clinical and Vaccine Immunology
- Lack of Homologous Protection Against Campylobacter jejuni CG8421 in a Human Challenge Model
- (2013) Beth D. Kirkpatrick et al. CLINICAL INFECTIOUS DISEASES
- Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine
- (2013) Francisco J. Martinez-Becerra et al. INFECTION AND IMMUNITY
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala
- (2013) Ronald H Behrens et al. LANCET INFECTIOUS DISEASES
- Oral Immunization with Cholera Toxin Provides Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model
- (2013) M. J. Albert et al. mBio
- Cooperative Role of Antibodies against Heat-Labile Toxin and the EtpA Adhesin in Preventing Toxin Delivery and Intestinal Colonization by Enterotoxigenic Escherichia coli
- (2012) Koushik Roy et al. Clinical and Vaccine Immunology
- Recent progress towards development of aShigellavaccine
- (2012) Ana Isabel Camacho et al. Expert Review of Vaccines
- The Type II Secretion System and Its Ubiquitous Lipoprotein Substrate, SslE, Are Required for Biofilm Formation and Virulence of Enteropathogenic Escherichia coli
- (2012) Deborah L. Baldi et al. INFECTION AND IMMUNITY
- Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal and affinity-matured gut IgA responses
- (2012) P Bergqvist et al. Mucosal Immunology
- The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens
- (2012) Susannah Leach et al. PLoS One
- Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
- (2011) Francisco J. Martinez-Becerra et al. INFECTION AND IMMUNITY
- Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine
- (2011) Mark S. Riddle et al. VACCINE
- A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)
- (2011) Chad K. Porter et al. VACCINE
- Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers
- (2010) D. Tribble et al. VACCINE
- Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
- (2010) Justen H. Passwell et al. VACCINE
- Mucosal Adjuvanticity of a Shigella Invasin Complex with DNA-Based Vaccines
- (2009) R. W. Kaminski et al. Clinical and Vaccine Immunology
- Inactivated and subunit vaccines to prevent shigellosis
- (2009) Robert W Kaminski et al. Expert Review of Vaccines
- Virulence, Inflammatory Potential, and Adaptive Immunity Induced by Shigella flexneri msbB Mutants
- (2009) R. T. Ranallo et al. INFECTION AND IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now